Q-Line Biotech (NSE:QLINE) Inventories, Work In Process: ₹23 Mil (As of Mar. 2025)


NSE:QLINE Q-Line Biotech Ltd NSE:QLINE
12 GF Score
Price ₹546.50
! 2 Warning Signs
View Full Analysis

What is Q-Line Biotech Inventories, Work In Process?

Q-Line Biotech NSE:QLINE -5.15% 12 Inventories, Work In Process is ₹23 Mil as of Mar. 2025. GuruFocus rates NSE:QLINE with a GF Score™ of 12/100. The stock has 2 warning signs investors should review.

Work in process is the part of a manufacturer's inventory that is in the production process and has not yet been completed and transferred to the finished goods inventory. Q-Line Biotech's work in process for the quarter that ended in Mar. 2025 was ₹23 Mil.

Q-Line Biotech Inventories, Work In Process Historical Data

* Premium members only.

The historical data trend for Q-Line Biotech's Inventories, Work In Process can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Q-Line Biotech Inventories, Work In Process Chart

Q-Line Biotech Annual Data
Trend Mar23 Mar24 Mar25
Inventories, Work In Process
0.27 35.12 23.45

Q-Line Biotech Semi-Annual Data
Mar23 Mar24 Mar25
Inventories, Work In Process 0.27 35.12 23.45
NSE:QLINE
12GF Score
Q-Line Biotech Ltd NSE:QLINE
Inventories, Work In Process is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Q-Line Biotech Inventories, Work In Process Calculation

That part of a manufacturer's inventory that is in the production process and has not yet been completed and transferred to the finished goods inventory. This account contains the cost of the direct material, direct labor, and factory overhead placed into the products on the factory floor. A manufacturer must disclose in its financial statements the cost of its work-in-process as well as the cost of finished goods and materials on hand.

What does a Inventories, Work In Process of ₹23 Mil mean?
Q-Line Biotech (NSE:QLINE) has a Inventories, Work In Process of ₹23 Mil as of Mar. 2025. Work in progress is the portion of inventory containing goods that are unfinished. View historical data on Q-Line Biotech and its competitors.
Is Q-Line Biotech's Inventories, Work In Process too high?
Q-Line Biotech's current Inventories, Work In Process is ₹23 Mil. Overall, Q-Line Biotech has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Q-Line Biotech's Inventories, Work In Process compare to ABT and SYK?
Q-Line Biotech's Inventories, Work In Process of ₹23 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Work In Process for a Medical Devices & Instruments company?
A good Inventories, Work In Process depends on the Medical Devices & Instruments industry context. However, Inventories, Work In Process should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Work In Process mean?
A high Inventories, Work In Process can signal that a stock is expensive relative to its fundamentals. Work in progress is the portion of inventory containing goods that are unfinished. View historical data on Q-Line Biotech and its competitors. Q-Line Biotech's current Inventories, Work In Process is ₹23 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Q-Line Biotech stock overvalued right now?
Q-Line Biotech (NSE:QLINE) has a current Inventories, Work In Process of ₹23 Mil. The current Inventories, Work In Process is ₹23 Mil. Q-Line Biotech's overall GF Score™ is 12/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Work In Process calculated?
Inventories, Work In Process is calculated from a company's financial statements. For Q-Line Biotech (NSE:QLINE), the current Inventories, Work In Process is ₹23 Mil as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Q-Line Biotech Business Description

Address Kanpur Road Adjacent Transport Nagar Metro Station, 298-281, Transport Nagar, Lucknow, UP, IND, 226012
Q-Line Biotech Ltd is engaged in the business of developing, manufacturing and marketing of diverse range of reagents (including kits and POC devices) & consumables and manufacturing, importing, distribution/supply of diagnostic equipment for different diagnostic healthcare needs. The company supplies diagnostic equipment and IVD products for different diagnostic healthcare needs directly or through its distributors majorly to diagnostic service providers, hospitals and medical colleges. It is engaged in Manufacturing and Trading into Biochemistry Regnant, Instruments and Consumables. The majority of revenue is derived from the Manufacturing segment.
12GF Score

Get the complete analysis for NSE:QLINE

Inventories, Work In Process is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹546.50
Price